Pharma News, 2017

Wednesday, multiple myeloma med Darzalex hit a development milestone, triggering a $20 million payment from Johnson & Johnson for Genmab.

Mylan and Biocon today became the first drugmakers to win an FDA approval of a biosimilar of Roche's blockbuster cancer drug Herceptin, a med that raked in $2.

(Reuters) - The U.

PARSIPPANY, NJ, USA I November 29, 2017 I The U.

Merck and Pfizer have revealed that a Phase III trial assessing avelumab in patients with gastric cancer after two prior therapeutic regimens failed to hit its primary target of showing an improvement...

(Reuters) - ViiV Healthcare, GlaxoSmithKline Plc’s HIV unit, said on Thursday it started an African study to evaluate long-acting injectable drug for the prevention of HIV infection in sexua...

(Reuters Health) - Nearly three in five children in the U.

 Geneva - An estimated 1 in 10 medical products circulating in low- and middle-income countries is either substandard or falsified, according to new research from WHO.

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has today announced Viagra Connect (containing sildenafil 5mg) will be formally classified from a prescription-only me...

American lawmakers meeting in a closed-door session reportedly received assurances from President Trump that he would be willing to support measures that would bolster the wobbling Obamacare exchange ...

Mumbai.

ViiV Healthcare has kicked off a late-stage study testing a long-acting, two-drug regimen of its cabotegravir and Janssen’s rilpivirine in virally suppressed adults with HIV-1 infection.